Literature DB >> 1320243

The murine ufo receptor: molecular cloning, chromosomal localization and in situ expression analysis.

M Faust1, C Ebensperger, A S Schulz, L Schleithoff, H Hameister, C R Bartram, J W Janssen.   

Abstract

We have cloned the mouse homologue of the ufo oncogene. It encodes a novel tyrosine kinase receptor characterized by a unique extracellular domain containing two immunoglobulin-like and two fibronectin type III repeats. Comparison of the predicted ufo amino acid sequences of mouse and man revealed an overall identity of 87.6%. The ufo locus maps to mouse chromosome 7A3-B1 and thereby extends the known conserved linkage group between mouse chromosome 7 and human chromosome 19. RNA in situ hybridization analysis established the onset of specific ufo expression in the late embryogenesis at day 12.5 post coitum (p.c.) and localized ufo transcription to distinct substructures of a broad spectrum of developing tissues (e.g. subepidermal cells of the skin, mesenchymal cells of the periosteum). In adult animals ufo is expressed in cells forming organ capsules as well as in connective tissue structures. ufo may function as a signal transducer between specific cell types of mesodermal origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320243

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

Review 1.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

Review 3.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Lutz Thon; Uwe Mamat; Paola Bellosta; Claudio Basilico; Dieter Adam; Ralf Paus; Silvia Bulfone-Paus
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

5.  A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation.

Authors:  D Besser; J F Bromberg; J E Darnell; H Hanafusa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 6.  Axl-dependent signalling: a clinical update.

Authors:  Vyacheslav A Korshunov
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

7.  Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.

Authors:  Q K Zhang; S Boast; K de los Santos; M Begemann; S P Goff
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.

Authors:  L Ling; H J Kung
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

9.  Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.

Authors:  Peter Vajkoczy; Pjotr Knyazev; Andrea Kunkel; Hans-Holger Capelle; Sandra Behrndt; Hendrik von Tengg-Kobligk; Fabian Kiessling; Uta Eichelsbacher; Marco Essig; Tracy-Ann Read; Ralf Erber; Axel Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 10.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.